Duloxetine in the treatment of melancholic depression

被引：0
|
作者：
Parker, G
Kelin, K
Brnabic, A
McBride, M
Kennedy, S
Sagman, D
Raskin, J
机构：
[1] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia
[2] Eli Lilly Australia, Clin Res, Sydney, NSW, Australia
[3] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[4] Eli Lilly Canada, Lilly Res Labs, Toronto, ON, Canada
来源：
BIOLOGICAL PSYCHIATRY | 2006年 / 59卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
128
引用
收藏
页码：40S / 40S
页数：1
相关论文
共 50 条
  • [41] Teaching and Conceptualization of Melancholic Depression
    Nutan Atre Vaidya
    Academic Psychiatry, 2011, 35 : 208 - 209
  • [42] Finding a biosignature for melancholic depression
    Day, Claire V. A.
    Williams, Leanne M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (07) : 835 - 847
  • [43] Duloxetine in the management of depression
    McAllister-Williams, R. Hamish
    FUTURE NEUROLOGY, 2006, 1 (06) : 713 - 720
  • [44] Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline
    Uher, Rudolf
    Dernovsek, Mojca Zvezdana
    Mors, Ole
    Hauser, Joanna
    Souery, Daniel
    Zobel, Astrid
    Maier, Wolfgang
    Henigsberg, Neven
    Kalember, Petra
    Rietschel, Marcella
    Placentino, Anna
    Mendlewicz, Julien
    Aitchison, Katherine J.
    McGuffin, Peter
    Farmer, Anne
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 132 (1-2) : 112 - 120
  • [45] Treatment resistance in severe unipolar depression: No association with psychotic or melancholic features
    Zaninotto, Leonardo
    Souery, Daniel
    Calati, Raffaella
    Sentissi, Othman
    Kasper, Siegfried
    Akimova, Elena
    Zohar, Joseph
    Montgomery, Stuart
    Mendlewicz, Julien
    Serretti, Alessandro
    ANNALS OF CLINICAL PSYCHIATRY, 2013, 25 (02) : 97 - 106
  • [46] Characterizing Cerebral Blood Perfusion and Treatment Outcomes in Atypical and Melancholic Depression
    Cooper, Crystal
    Trombello, Joseph
    Fatt, Cherise Chin
    Patem, Ethan
    Fava, Maurizio
    McGrath, Patrick
    Parsey, Ramin
    Weissman, Myrna
    Phillips, Mary
    Lu, Hanzhang
    Trivedi, Madhukar
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S94 - S94
  • [47] Duloxetine versus sertraline in treatment of depression in Parkinson's disease
    Scarella, L.
    Scarella, G.
    Costanza, A.
    Di Stasi, M.
    Vastola, K.
    MOVEMENT DISORDERS, 2008, 23 (01) : S200 - S200
  • [48] Functioning in Patients with Major Depression Receiving Treatment with SSRIs or Duloxetine
    Novick, Diego
    Montgomery, William
    Victoria Moneta, Maria
    Duenas, Hector
    Brugnol, Roberto
    Yue, Li
    Maria Haro, Josep
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 : S31 - S31
  • [49] Duloxetine -: a new option for the treatment of depression and painful somatic symptoms
    Möller, HJ
    PSYCHOPHARMAKOTHERAPIE, 2005, 12 (06): : 12 - 14
  • [50] Efficacy and safety of duloxetine 120 mg/day in the treatment of depression
    Goldstein, DJ
    Mallinckrodt, C
    Lu, Y
    Detke, M
    Demitrack, MA
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (01) : 108 - 108
12345